Publications of Philip Maximilian Knaff
All genres
Journal Article (4)
2022
Journal Article
5 (1), 681 (2022)
Peptidomimetic inhibitors of TMPRSS2 block SARS-CoV-2 infection in cell culture. Communications Biology
Journal Article
29 (4), pp. 635 - 665 (2022)
Interface with Host Proteases in SARS-CoV-2 Entry as a Promising Therapeutic Strategy. Current Medicinal Chemistry 2021
Journal Article
12, 1726 (2021)
Alpha-1 antitrypsin inhibits TMPRSS2 protease activity and SARS-CoV-2 infection. Nature Communications 2020
Journal Article
21 (4), pp. 1636 - 1643 (2020)
From In Silico to Experimental Validation: Tailoring Peptide Substrates for a Serine Protease. Biomacromolecules Thesis - PhD (1)
2021
Thesis - PhD
Development of Peptidomimetic Substrates and Inhibitors for Transmembrane Serine Proteases. Dissertation, Johannes Gutenberg-Universität, Mainz (2021)
Patent (1)
2021
Patent
SELECTIVE TMPRSS2 INHIBITORS AND MEDICAL USE THEREOF. (2021)